EN | TR
E-ISSN: 2149-6447
Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Diagnosis and Staging of Lung Cancer
PDF
Cite
Share
Request
Review
VOLUME: 4 ISSUE: 1
P: 6-17
March 2018

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Diagnosis and Staging of Lung Cancer

Nucl Med Semin 2018;4(1):6-17
DOI: 10.4274/nts.2018.002
Ümit Özgür Akdemir 1
Uğuray Aydos 2
1. Gazi Üniversitesi Tıp Fakültesi, Nükleer Tıp Anabilim Dalı, Ankara, Türkiye
2. Ankara Atatürk Eğitim ve Araştırma Hastanesi, Nükleer Tıp Kliniği, Ankara, Türkiye
No information available.
No information available
Publish Date: 27.03.2018
PDF
Cite
Share
Request

ABSTRACT

Positron emission tomography/computed tomography (PET/CT) using fluorine-18 labelled fluorodeoxyglucose (FDG) is a powerful tool for managing patients with suspected lung nodules and lung cancer. In this review, we discuss the utility of FDG PET/CT imaging in evaluation of suspected pulmonary nodules and initial staging of patients with newly diagnosed lung cancer, prognostic value of quantitative PET parameters, technical developments in PET imaging such as hybrid PET/magnetic resonance systems, and the use of other PET radiopharmaceuticals related to lung cancer pathophysiology.